SLIDE 7 Page 7
Jehle S, et. al. J Clin Endocrinol Metab. 2013 Jan;98(1):207-17.
N=201 60% female 25(OH)vit D = 24 + 8 ng/ml L Spine T-score = -0.6 + 1.5 Kcitrate 60 mmol/day vs. pbo NAE negative on Kcitrate ↑ trabecular thickness, number on QCT.
L2-L4
n=91 n=84 n=86 n=87 n=91 n=85 n=86 n=87 1.7% (1.0-2.3)
24 18 12 6
0.5 1 1.0 2 2.5 3 Kcitrate Placebo Months % Change in BMD †† †† † xx xx xx 24 18 12 6
n=91 n=84 n=86 n=87 n=90 n=85 n=86 n=87 1.0% (0.5-1.5)
1 0.5
2 1.5 Kcitrate Placebo
Total Hip
% Change in BMD Months † x † x † xx x=p<0.05; xx=p<0.001, Kcitrate vs. placebo †=p<0.05;††=p<0.001, compared to baseline
KCitrate and BMD
Isoflavones/Soy
- Plant compounds (phytoestrogens) found in
soybeans, clover, alfalfa sprouts
- Studies on bone health mixed
– Interventions varied – Different compounds may offset each other – Effects may depend on proximity to menopause – Equol producers – 2 placebo controlled RCTs neg